Business
Buffalo Capital Inc. announces mailing of information circular and provides transaction update
Buffalo Capital Inc. announces mailing of information circular and provides transaction up...
About this update from Waverley Pharma, Inc.
[{"type":"text","content":"\n\n\n\nBuffalo Capital Inc. announces mailing of information circular and provides transaction update\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nWINNIPEG, Sept. 15, 2017\n\n\n\n/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FORDISSEMINATION IN THE UNITED STATES./\n\n\n\nWINNIPEG, Sept. 15, 2017 /CNW/ - Buffalo Capital Inc. (\"Buffalo\" or the \"Company\") (TSXV: BUFF.P) is pleased to announce that it has mailed an information circular dated August 28, 2017 (the \"Circular\") to its shareholders in connection with an annual and special meeting of Buffalo shareholders to be held on October 8, 2017 (the \"Meeting\").  At the Meeting, Buffalo shareholders will be asked, among other matters, to approve the Company's previously announced non-arm's length amalgamation (the \"Amalgamation\") with Waverley Pharma Inc. (\"Waverley\").  A copy of the Circular is available on Buffalo's SEDAR profile at www.sedar.com.  The Amalgamation is expected to constitute Buffalo's Qualifying Transaction (as such term is defined in the policies of the TSX Venture Exchange (\"TSXV\")).\n\nThe Company is also pleased to announce that Waverley's wholly-owned subsidiary, Waverley Pharma International Inc. (\"WPI\"), has entered into a License, Manufacture and Supply Agreement with Reliance Life Sciences Private Limited pursuant to which WPI acquired an exclusive license to market, sell and distribute two generic oncology drugs, WAV-101 and WAV-102, in the United States of America and its territories (Puerto Rico, Guam and the U.S. Virgin Islands), Canada and the European Union (other than the United Kingdom) and a non-exclusive license to market, sell and distribute WAV-101 and WAV-102 in the United Kingdom.  A copy of the License, Manufacture and Supply Agreement will be made available on Buffalo's SEDAR profile at www.sedar.com.\n\nTrading in Buffalo's shares was voluntarily halted on August 8, 2017 and is expected to remain halted pending completion or termination of the Amalgamation.\n\nAbout Buffalo...